GoodRx, a disruptive medical prescription cost platform, recently debuted as GDRX on the stock market. CEO Doug Hirsch shares insights on earnings and business growth. Investors eyeing GDRX stock should monitor its performance, especially approaching the March 2024 trading broker alert. Evaluate GDRX's potential in reshaping the healthcare industry.